Clinical Trial Update: Efficacy and Safety of Varenicline Among HIV-infected Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of varenicline for smoking cessation in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infections, Tobacco Dependence | Phase 3 | Status: COMPLETED